- Home
- SST vs ME Comparison
SST vs ME Comparison
Compare SST & ME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SST
- ME
- Stock Information
- Founded
- SST 2013
- ME 2006
- Country
- SST United States
- ME United States
- Employees
- SST N/A
- ME N/A
- Industry
- SST Diversified Commercial Services
- ME Precision Instruments
- Sector
- SST Consumer Discretionary
- ME Health Care
- Exchange
- SST Nasdaq
- ME Nasdaq
- Market Cap
- SST 67.8M
- ME 40.0M
- IPO Year
- SST N/A
- ME N/A
- Fundamental
- Price
- SST $0.46
- ME $1.82
- Analyst Decision
- SST Buy
- ME Hold
- Analyst Count
- SST 2
- ME 1
- Target Price
- SST $3.50
- ME $9.40
- AVG Volume (30 Days)
- SST 144.3K
- ME 466.4K
- Earning Date
- SST 03-10-2025
- ME 01-28-2025
- Dividend Yield
- SST N/A
- ME N/A
- EPS Growth
- SST N/A
- ME N/A
- EPS
- SST N/A
- ME N/A
- Revenue
- SST $343,925,000.00
- ME $208,775,000.00
- Revenue This Year
- SST $8.34
- ME $22.00
- Revenue Next Year
- SST N/A
- ME $17.31
- P/E Ratio
- SST N/A
- ME N/A
- Revenue Growth
- SST N/A
- ME N/A
- 52 Week Low
- SST $0.42
- ME $1.34
- 52 Week High
- SST $2.73
- ME $12.76
- Technical
- Relative Strength Index (RSI)
- SST 34.30
- ME 37.81
- Support Level
- SST $0.45
- ME $1.48
- Resistance Level
- SST $0.58
- ME $1.75
- Average True Range (ATR)
- SST 0.06
- ME 0.17
- MACD
- SST -0.00
- ME 0.02
- Stochastic Oscillator
- SST 14.59
- ME 40.43
About SST System1 Inc.
System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It serves customers in the areas of health and wellness, automotive, finance, travel, and entertainment. The company's segment includes Owned and Operated Advertising (O&O); and Partner Network. It generates maximum revenue from the Owned and Operated Advertising (O&O) segment.
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.